0
0
26 words
0
Comments
A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic dysfunction–associated steatotic liver disease.
You are the first to view
https://www.medscape.com/viewarticle/ada-issues-new-masld-guidelines-2025a1000esb
Create an account or login to join the discussion